Article
Collaboration to Transition Members to Preferred Formulary Dipeptidyl-Peptidase-4 Inhibitor
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes
How Can Employers Leverage the DPP to Improve Diabetes Rates?
Team-Based CINEMA Program Targets SDOH and Precision Care in Diabetes
Early Diabetes Screening in Pregnancy: Challenges and Opportunities